globalbarry. Company Intelligence Engine

C21 Investments Inc.

CWLXF CIK 0000831609 · Medicinal Chemicals & Botanical Products (SIC 2833)

Disclosed SEC business address
SUITE 1900-855 WEST GEORGIA STREET, VANCOUVER, V6C 3H4

C21 Investments Inc. (ticker CWLXF, CIK 0000831609) is tracked by Global Barry from its public SEC filings and disclosures. Disclosed industry classification: Medicinal Chemicals & Botanical Products (SIC 2833). Every item is grounded on the cited public source — no figures are fabricated.

Top findings public preview

  • FACT Disclosed industry: Medicinal Chemicals & Botanical Products (SIC 2833)
  • UNKNOWN Country of disclosed business address: Unavailable
  • FACT 6-K filed (period 2026-06-30) 2026-08-21 source ↗

Full evidence detail

Company deep views this month: 3 of 5.

Filing intelligence

105 filings ingested; deep FILING ANALYSIS shown for 6 filings.

  • FACT Only one ingested version of this accession exists; no intra-document revisions have been observed. Change tracking for this filing requires ≥2 ingested versions. 2026-08-21 source ↗
  • ANALYSIS This 6-K was filed 11 days after the previous ingested 6-K (2026-08-10). 85 filings of this type are ingested. 2026-08-21 source ↗
  • UNKNOWN Changed risk-factor language (Item 1A): not derivable from ingested evidence. Current ingestion retains filing metadata, XBRL financial facts, insider-ownership disclosures, and the issuer submission snapshot — not the full filing document body. This item would require ingesting the filing's primary document text. 2026-08-21 source ↗
  • UNKNOWN MD&A highlights: not derivable from ingested evidence. Current ingestion retains filing metadata, XBRL financial facts, insider-ownership disclosures, and the issuer submission snapshot — not the full filing document body. This item would require ingesting the filing's primary document text. 2026-08-21 source ↗
  • UNKNOWN Material business developments: not derivable from ingested evidence. Current ingestion retains filing metadata, XBRL financial facts, insider-ownership disclosures, and the issuer submission snapshot — not the full filing document body. This item would require ingesting the filing's primary document text. 2026-08-21 source ↗
  • UNKNOWN Debt / capital-structure changes: not derivable from ingested evidence. Current ingestion retains filing metadata, XBRL financial facts, insider-ownership disclosures, and the issuer submission snapshot — not the full filing document body. This item would require ingesting the filing's primary document text. 2026-08-21 source ↗
  • UNKNOWN Acquisitions / divestitures: not derivable from ingested evidence. Current ingestion retains filing metadata, XBRL financial facts, insider-ownership disclosures, and the issuer submission snapshot — not the full filing document body. This item would require ingesting the filing's primary document text. 2026-08-21 source ↗
  • UNKNOWN Litigation / regulatory matters: not derivable from ingested evidence. Current ingestion retains filing metadata, XBRL financial facts, insider-ownership disclosures, and the issuer submission snapshot — not the full filing document body. This item would require ingesting the filing's primary document text. 2026-08-21 source ↗

Latest developments

Most recent SEC filing events ingested for this company (newest first).

  • FACT 6-K filed (period 2026-06-30) 2026-08-21 source ↗
  • FACT 6-K filed (period 2026-08-07) 2026-08-10 source ↗
  • FACT 6-K filed (period 2026-08-07) 2026-07-09 source ↗
  • FACT 6-K filed (period 2026-06-19) 2026-06-22 source ↗
  • FACT 6-K filed (period 2026-06-15) 2026-06-15 source ↗
  • FACT 20-F filed (period 2026-03-31) 2026-06-12 source ↗
  • FACT 6-K filed (period 2026-03-31) 2026-06-12 source ↗
  • FACT S-8 filed 2026-03-19 source ↗
  • FACT 6-K filed (period 2026-02-10) 2026-02-10 source ↗
  • FACT 6-K filed (period 2025-12-31) 2026-02-10 source ↗

Insider ownership filings

No insider ownership filings (Forms 3/4/5) have been ingested for this company. This is not a claim that none exist.

  • UNKNOWN No insider ownership filings (Forms 3/4/5) have been ingested for this company. This is not a claim that none exist.

Geographic footprint (disclosed)

Geographic footprint limited to locations disclosed in ingested evidence.

  • FACT Principal executive office (disclosed): VANCOUVER, V6C 3H4
  • FACT Mailing address (disclosed): VANCOUVER, V6C 3H4
  • FACT State/country of incorporation (disclosed): British Columbia, Canada

Industry classification (disclosed)

Industry classification as disclosed by the issuer's SEC record.

  • FACT Primary industry (disclosed SIC): Medicinal Chemicals & Botanical Products (SIC 2833)
  • FACT SEC filer category: Non-accelerated filer<br>Emerging growth company

Supply chain

No supplier or customer relationships are disclosed in ingested evidence. Supply-chain relationships are shown only when explicitly disclosed and cited; undisclosed relationships are never inferred.

  • UNKNOWN No supplier or customer relationships are disclosed in ingested evidence. Supply-chain relationships are shown only when explicitly disclosed and cited; undisclosed relationships are never inferred.

Risk factors

Risk-factor language requires ingested filing document bodies.

  • UNKNOWN Risk-factor language requires ingested filing document bodies.

Sources

Grounded on public SEC filings and disclosures with explicit evidence tiers and citations. This page is informational only and is not investment advice. No figures are fabricated; unavailable data is shown as unavailable.